Análise de custo-efetividade da adição de abiraterona ou quimioterapia ao tratamento do câncer de próstata metastático hormônio-sensível

Autor: Pui San Tan, Auro Del Giglio, Carmelia Maria Noia Barreto, Gilberto Lopes, Pedro Nazareth Aguiar, Barbara de Souza Gutierres, Sarah Simko

Publikováno v: Einstein (São Paulo), Vol 17, Iss 2
Einstein
Einstein (São Paulo), Volume: 17, Issue: 2, Article number: eGS4414, Published: 07 MAR 2019
einstein (São Paulo) v.17 n.2 2019
Einstein (São Paulo)
Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron:IIEPAE

Objective To evaluate the cost-effectiveness of the addition of chemotherapy or abiraterone to androgen deprivation. Methods We developed an analytical model to determine the cost-effectiveness of the addition of docetaxel or abiraterone versus andro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c959ebcf78346ef17389f71ba46c435
https://pubmed.ncbi.nlm.nih.gov/30843996

Cost-effectiveness analysis of abiraterone, docetaxel or placebo plus androgen deprivation therapy for hormone-sensitive advanced prostate cancer.

Autor: Aguiar Jr., Pedro Nazareth^1,2 pnajpg@hotmail.com, Pui San Tan³, Simko, Sarah⁴, Barreto, Carmelia Maria Noia⁵, de Souza Gutierres, Bárbara⁶, del Giglio, Auro¹, de Lima Lopes Jr., Gilberto⁷

Publikováno v: Einstein (16794508). 2019, Vol. 17 Issue 2, p1-6. 6p.